Granules' US unit gets two USFDA observations

As per the USFDA, a Form 483, is issued to a firm's management at the conclusion of an inspection when investigator has observed any conditions that in its judgment may constitute violations of FD&C Act.

Source: The Economic Times Healthcare and Biotech News - October 29, 2018 Category: Pharmaceuticals Source Type: news